DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Alvarez, Sara ^a   Suela, Javier ^a   Valencia, Ana ^b   Fernández, Agustín ^c   Wunderlich, Mark ^d   Agirre, Xabier ^e   Prósper, Felipe ^e   Martín Subero, José Ignacio ^c,h   Maiques, Alba ^a   Acquadro, Francesco ^a   Perales, Sandra Rodriguez ^a   Calasanz, María José ^f   Roman Gómez, Jose ^g   Siebert, Reiner ^h   Mulloy, James C ^d   Cervera, José ^b   Sanz, Miguel Angel ^b   Esteller, Manel ^c   Cigudosa, Juan C ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF NAVARRA   (Spain)

^f UNIVERSITY OF NAVARRA   (Spain)

^g HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^h UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; DBC1 PROTEIN, HUMAN; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; CPG ISLAND; CYTOGENETICS; DISEASE FREE SURVIVAL; DNA METHYLATION; EPIGENETICS; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROTEIN FUNCTION; VALIDITY; GENETIC EPIGENESIS; GENETIC VARIABILITY; GENETICS; HUMAN CHROMOSOME; KARYOTYPING; METABOLISM; MIDDLE AGED;

ADULT; CHROMOSOMES, HUMAN; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENETIC VARIATION; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PROGNOSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 77957928566     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012197     Document Type: Article

References (39)

1. Gilliland DG (2001) Hematologic malignancies. Curr Opin Hematol 8: 189-191.
2. Frohling S, Scholl C, Gilliland DG, Levine RL (2005) Genetics of myeloid malignancies: pathogenetic and clinical implications. J Clin Oncol 23: 6285-6295.
3. Esteller M, Fraga MF, Paz MF, Campo E, Colomer D, et al. (2002) Cancer epigenetics and methylation. Science 297: 1807-1808; discussion 1807-1808.
4. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128: 683-692.
5. Galm O, Herman JG, Baylin SB (2006) The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev 20: 1-13.
6. Toyota M, Kopecky KJ, Toyota MO, Jair KW, Willman CL, et al. (2001) Methylation profiling in acute myeloid leukemia. Blood 97: 2823-2829.
7. Kroeger H, Jelinek J, Estecio MR, He R, Kondo K, et al. (2008) Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse. Blood 112: 1366-1373.
8. Bullinger L, Ehrich M, Dohner K, Schlenk RF, Dohner H, et al. (2010) Quantitative DNA methylation predicts survival in adult acute myeloid leukemia. Blood 115: 636-642.
9. Figueroa ME, Lugthart S, Li Y, Erpelinck-Verschueren C, Deng X, et al. (2010) DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia. Cancer Cell.
10. Shen L, Kantarjian H, Guo Y, Lin E, Shan J, et al. (2010) DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes. J Clin Oncol 28: 605-613.
11. Boultwood J, Wainscoat JS (2007) Gene silencing by DNA methylation in haematological malignancies. Br J Haematol 138: 3-11.
12. Suarez L, Vidriales MB, Moreno MJ, Lopez A, Garcia-Larana J, et al. (2005) Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells. Haematologica 90: 54-59.
13. Wei J, Wunderlich M, Fox C, Alvarez S, Cigudosa JC, et al. (2008) Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. Cancer Cell 13: 483-495.
14. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, et al. (2006) High throughput DNA methylation profiling using universal bead arrays. Genome Res 16: 383-393.
15. Fan JB, Oliphant A, Shen R, Kermani BG, Garcia F, et al. (2003) Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol 68: 69-78.
16. Martin-Subero JI, Kreuz M, Bibikova M, Bentink S, Ammerpohl O, et al. (2009) New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood 113: 2488-2497.
17. Martin-Subero JI, Ammerpohl O, Bibikova M, Wickham-Garcia E, Agirre X, et al. (2009) A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS ONE 4: e6986.
18. Takai D, Jones PA (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 99: 3740-3745.
19. San Jose-Eneriz E, Agirre X, Roman-Gomez J, Cordeu L, Garate L, et al. (2006) Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoter. Br J Haematol 134: 137-144.
20. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, et al. (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102: 10604-10609.
21. Diaz-Uriarte R (2008) SignS: a parallelized, open-source, freely available, web based tool for gene selection and molecular signatures for survival and censored data. BMC Bioinformatics 9: 30.
22. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
23. Martin V, Valencia A, Agirre X, Cervera J, Jose-Eneriz ES, et al. (2009) Epigenetic Regulation of Non-Canonical Wnt Pathway in Acute Myeloid Leukemia. Cancer Sci.
24. Valencia A, Roman-Gomez J, Cervera J, Such E, Barragan E, et al. (2009) Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia. Leukemia 23: 1658-1666.
25. Opavsky R, Wang SH, Trikha P, Raval A, Huang Y, et al. (2007) CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells. PLoS Genet 3: 1757-1769.
26. Li Z, Luo RT, Mi S, Sun M, Chen P, et al. (2009) Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias. Cancer Res 69: 1109-1116.
27. Iwasaki H, Mizuno S, Arinobu Y, Ozawa H, Mori Y, et al. (2006) The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev 20: 3010-3021.
28. Xie H, Ye M, Feng R, Graf T (2004) Stepwise reprogramming of B cells into macrophages. Cell 117: 663-676.
29. Mulloy JC, Cammenga J, MacKenzie KL, Berguido FJ, Moore MA, et al. (2002) The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. Blood 99: 15-23.
30. Wunderlich M, Krejci O, Wei J, Mulloy JC (2006) Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability. Blood 108: 1690-1697.
31. Hess CJ, Errami A, Berkhof J, Denkers F, Ossenkoppele GJ, et al. (2008) Concurrent methylation of promoters from tumor associated genes predicts outcome in acute myeloid leukemia. Leuk Lymphoma 49: 1132-1141.
32. Nishiyama H, Gill JH, Pitt E, Kennedy W, Knowles MA (2001) Negative regulation of G(1)/S transition by the candidate bladder tumour suppressor gene DBCCR1. Oncogene 20: 2956-2964.
33. Rosu-Myles M, Wolff L (2008) p15Ink4b: dual function in myelopoiesis and inactivation in myeloid disease. Blood Cells Mol Dis 40: 406-409.
34. Wong IH, Ng MH, Huang DP, Lee JC (2000) Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications. Blood 95: 1942-1949.
35. Gronbaek K, Ralfkiaer U, Dahl C, Hother C, Burns JS, et al. (2008) Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasms. Mod Pathol 21: 632-638.
36. Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, et al. (2009) Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood 113: 1315-1325.
37. Habuchi T, Luscombe M, Elder PA, Knowles MA (1998) Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. Genomics 48: 277-288.
38. Izumi H, Inoue J, Yokoi S, Hosoda H, Shibata T, et al. (2005) Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers. Hum Mol Genet 14: 997-1007.
39. Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, et al. (2002) Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 100: 4325-4336.